Skip to main content
Publications
Twiss J, Whalley D, Doward L, Balp MM, Brass C, Lopez P, Loeffler J, Cai J, Cryer D, Sanyal AJ, Anstee QM. Psychometric evaluation of NASH-CHECK, a patient-reported outcome measure for Nonalcoholic Steatohepatitis. Poster presented at the ISPOR 2019 European Conference; November 6, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).
Lopez-Vicente M, Ribas Fito N, Vilor-Tejedor N, Garcia-Esteban R, Fernandez-Barres S, Dadvand P, Murcia M, Rebagliato M, Ibarluzea J, Lertxundi A, Fernandez-Somoano A, Tardon A, Lopez-Sabater MC, Romaguera D, Vrijheid M, Sunyer J, Julvez J. Prenatal omega-6:omega-3 ratio and attention deficit and hyperactivity disorder symptoms. J Pediatr. 2019 Jun;209:204-211.e. doi: 10.1016/j.jpeds.2019.02.022
Fernandez-Barres S, Vrijheid M, Manzano-Salgado CB, Valvi D, Martinez D, Iniguez C, Jimenez-Zabala A, Riano-Galan I, Navarrete-Munoz EM, Santa-Marina L, Tardon A, Vioque J, Arija V, Sunyer J, Romaguera D, Infancia y Medio Ambiente (INMA) Project. The association of Mediterranean Diet during pregnancy with longitudinal body mass index trajectories and cardiometabolic risk in early childhood. J Pediatr. 2019 Mar;206:119-27. doi: 10.1016/j.jpeds.2018.10.005
Herring W, Gould IG, Casamassima G, Dort T, Zhang Y, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase Registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in Italy. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 12, 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(Suppl 3):S338.
Herring W, Gould IG, Ruiz L, Dort T, Zhang Y, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase Registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in Spain. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 12, 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(Suppl 3):S338.
Trantham L, Klein AB, Parikh RC, Kurosky S, Zhang Y, Levine CA, Kaye JA. Unresectable, locally advanced, stage III non-small cell lung cancer: real-world clinical characteristics, treatment patterns, and health care resource utilization in Europe. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 22, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S49. doi: 10.1016/j.jval.2018.04.289